Skip to main content
. 2008 Jul 7;52(9):3350–3357. doi: 10.1128/AAC.00360-08

FIG. 2.

FIG. 2.

Concentration-time profile of oritavancin in mouse plasma after administration of a single 32-mg/kg dose by either the i.v. or the i.p. route. While total (bound plus free) oritavancin concentrations were measured, calculated free oritavancin concentrations, based on 93.6% protein binding in mouse serum, are plotted.